Liu, W., Zhuang, C., Huang, T., Yang, S., Zhang, M., Lin, B., & Jiang, Y. (2020). Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression. Wiley.
Cita Chicago Style (17a ed.)Liu, Wei, Congwen Zhuang, Tengfei Huang, Shengsheng Yang, Meiqing Zhang, Baoquan Lin, y Yi Jiang. Loss of CDKN2A at Chromosome 9 Has a Poor Clinical Prognosis and Promotes Lung Cancer Progression. Wiley, 2020.
Cita MLA (9a ed.)Liu, Wei, et al. Loss of CDKN2A at Chromosome 9 Has a Poor Clinical Prognosis and Promotes Lung Cancer Progression. Wiley, 2020.
Precaución: Estas citas no son 100% exactas.